Beam Therapeutics Inc (BEAM)

Apr 09, 2026

BEAM Price Today: Beam Therapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 09, 2026

Apr 09, 2026

Beam Therapeutics President Sells $290,289 in Stock - National Today

Apr 09, 2026

Apr 08, 2026

(BEAM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Apr 08, 2026

Apr 07, 2026

Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications - GlobeNewswire Inc.

Apr 07, 2026

Apr 07, 2026

Beam Therapeutics CEO Sells Over $700K in Stock - National Today

Apr 07, 2026

Apr 06, 2026

Beam Therapeutics Insider Sells $146K in Shares - National Today

Apr 06, 2026

Apr 06, 2026

JonesTrading Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $35 - Moomoo

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics CEO Evans sells $739k in stock By Investing.com - Investing.com Australia

Apr 06, 2026

Apr 06, 2026

Amy Simon, Beam Therapeutics CMO, sells $164,686 in stock By Investing.com - Investing.com India

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics (NASDAQ:BEAM) Insider Amy Simon Sells 6,700 Shares of Stock - MarketBeat

Apr 06, 2026

Apr 06, 2026

John Evans Sells 30,078 Shares of Beam Therapeutics (NASDAQ:BEAM) Stock - MarketBeat

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics (NASDAQ:BEAM) Insider Christine Bellon Sells 5,956 Shares - MarketBeat

Apr 06, 2026

Apr 06, 2026

Bethany Cavanagh (Beam Therapeutics) sells $79,688 in BEAM stock By Investing.com - Investing.com Australia

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics president sells $290k in shares By Investing.com - Investing.com Australia

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics CEO Evans sells $739k in stock - Investing.com

Apr 06, 2026

Apr 06, 2026

Amy Simon, Beam Therapeutics CMO, sells $164,686 in stock - Investing.com

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics president sells $290k in shares - Investing.com

Apr 06, 2026

Apr 06, 2026

[Form 4] Beam Therapeutics Inc. Insider Trading Activity - Stock Titan

Apr 06, 2026

Apr 06, 2026

Bethany Cavanagh (Beam Therapeutics) sells $79,688 in BEAM stock - Investing.com

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics (BEAM) CMO covers tax obligations via 6,700-share sale - Stock Titan

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics (BEAM) SVP auto-sells shares to cover RSU tax obligations - Stock Titan

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics (BEAM) CLO auto-sells 5,956 shares for RSU tax withholding - Stock Titan

Apr 06, 2026

Apr 06, 2026

Beam Therapeutics (BEAM) president’s 11,810-share sale covers RSU taxes - Stock Titan

Apr 06, 2026

Apr 05, 2026

BEAM SEC FilingsBeam Therapeutics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 05, 2026

Apr 04, 2026

Beam Therapeutics Inc. (BEAM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026

Apr 04, 2026

SG Americas Securities LLC Boosts Beam Therapeutics Stake by 139% - National Today

Apr 04, 2026

Apr 04, 2026

SG Americas Securities LLC Acquires 60,249 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat

Apr 04, 2026

Apr 03, 2026

Beam Therapeutics Inc. (BEAM) stock price, news, quote and history - Yahoo Finance Australia

Apr 03, 2026

Apr 03, 2026

Intellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

Beam Therapeutics Inc. (BEAM) interactive stock chart - sg.finance.yahoo.com

Apr 03, 2026

Apr 02, 2026

Beam Therapeutics (NASDAQ: BEAM) awards 20,000 RSUs to Chief Legal Officer - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) awards 20,000 RSUs to SVP Bethany Cavanagh - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) awards 31,750 RSUs to Chief Medical Officer Amy Simon - Stock Titan

Apr 02, 2026

Apr 02, 2026

CFO of Beam Therapeutics (NASDAQ: BEAM) awarded 31,750 RSUs - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM) grants president 40,000 restricted stock units - Stock Titan

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM): Among the stocks that could 10x over the next 5 years - MSN

Apr 02, 2026

Apr 02, 2026

Insider Selling: Beam Therapeutics (NASDAQ:BEAM) CEO Sells 25,000 Shares of Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics (BEAM): Among the Stocks That Could 10x Over the Next 5 Years - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics Insider Sold Shares Worth $1,128,315, According to a Recent SEC Filing - Moomoo

Apr 02, 2026

Apr 02, 2026

Beam Therapeutics shares climb after positive BEAM-302 trial update - MSN

Apr 02, 2026

Apr 02, 2026

BEAM Stock Price, Quote & Chart | BEAM THERAPEUTICS INC (NASDAQ:BEAM) - ChartMill

Apr 02, 2026

Apr 02, 2026

Beam (BEAM) Reports Promising Data from BEACON Trial in Sickle C - GuruFocus

Apr 02, 2026

Apr 01, 2026

Beam Therapeutics publishes sickle cell therapy trial data By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Why Is BEAM Stock Edging Higher After Hours Today? - Stocktwits

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics CEO Evans sells $1.1m in stock By Investing.com - in.investing.com

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics CEO Evans sells $1.1m in stock - Investing.com

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics (BEAM) CEO sells 50K shares, gains 90K RSUs - Stock Titan

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics publishes sickle cell therapy trial data - Investing.com

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine - The Manila Times

Apr 01, 2026

Apr 01, 2026

Beam Therapeutics Announces Publication of BEACON Phase 1/2 - GlobeNewswire

Apr 01, 2026

Apr 01, 2026

In 31 sickle cell patients, Beam saw no severe pain crises after risto-cel - Stock Titan

Apr 01, 2026

Mar 31, 2026

[144] Beam Therapeutics Inc. SEC Filing - Stock Titan

Mar 31, 2026

Mar 31, 2026

ETRADE Financial (NASDAQ: BEAM) insider sales and restricted vesting - Stock Titan

Mar 31, 2026